Logo image of TNXP

TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Analyst Ratings

USA - NASDAQ:TNXP - US8902608392 - Common Stock

25.08 USD
+0.92 (+3.81%)
Last: 10/1/2025, 9:39:46 AM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to TNXP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 62.9. This target is 150.8% above the current price.
TNXP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TNXP.
In the previous month the buy percentage consensus was at a similar level.
TNXP was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

TNXP Historical Analyst RatingsTNXP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -105 -95 -85 -75 -65 -55 -45 -35 -25 -15 -5 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 25.0850.5066.3062.9073.50 - 101.36% 164.35% 150.80% 193.06%

Related screens

TNXP Current Analyst RatingTNXP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-03-20 Noble Capital Markets Reiterate Outperform -> Outperform
2024-07-22 Alliance Global Partners Maintains Buy -> Buy
2024-02-28 Dawson James Initiate Buy
2023-08-01 Alliance Global Partners Maintains Buy -> Buy
2023-06-02 Alliance Global Partners Maintains Buy -> Buy
2023-01-12 Alliance Global Partners Reiterate Buy
2022-04-18 Noble Capital Markets Initiate Outperform